Fever is one of the body’s natural defenses against infection, but it can also cause fatigue, discomfort, and dehydration, especially during viral illnesses like dengue. Ibuprofen, one of the most trusted over-the-counter medications in Latin America, helps reduce fever and inflammation by blocking prostaglandins and resetting the body’s thermostat. Learn how this essential drug works and how to use it safely.
New research shows that H. pylori, a common stomach infection, may raise the risk of fatty liver disease in Hispanics, especially Puerto Rican and Mexican adults. With nearly half of participants affected, the study highlights the need for early screening and awareness in Latino communities already burdened by obesity and diabetes.
Helicobacter pylori (H. pylori) is more than just a stomach infection, it’s a hidden threat with serious consequences for Hispanic health. Beyond ulcers and gastritis, research shows links to gastric cancer, liver disease, and even metabolic disorders. Because Hispanic populations face higher infection rates, awareness, early detection, and treatment are critical in reducing long-term risks and improving overall health.
Rising antibiotic resistance is undermining H. pylori treatment in Latin America, with high resistance to metronidazole (53%) and clarithromycin (12%). Experts urge regional surveillance and recommend switching to regimens with lower resistance, like amoxicillin or tetracycline.
Affecting millions worldwide and hitting Hispanic and Latino communities hardest, this silent infection spreads easily in close living conditions. Knowing how H. pylori spreads is crucial to preventing infection and protecting your family.
Women in Latin America may face a higher risk of severe dengue due to biological, social, and behavioral factors. From pregnancy complications to increased mosquito exposure at home, the dangers are real. This post explores why women need extra protection, and the top three steps they can take to stay safe during dengue outbreaks.
As Latin American women continue to lead in politics, science, and entrepreneurship, they face a quieter but growing threat: dengue. In 2024 alone, the region saw over 13 million dengue cases, with new research revealing that women, especially those of reproductive age, are more likely to suffer severe complications. From biological factors like estrogen’s impact on immunity to social roles that increase mosquito exposure, the gender gap in arboviral infections is real and urgent. With evidence mounting from countries like Brazil, experts are calling for gender-sensitive public health strategies, including targeted vector control, reproductive care, and expanded vaccine access to protect those most at risk.
Oropouche virus (OROV) and dengue virus (DENV) share overlapping symptoms like fever and headache, but key differences, such as sore throat and abdominal pain, can help with early diagnosis and effective treatment. This article breaks down the latest clinical findings, explores the biological mechanisms behind these symptoms, and recommends safe over-the-counter (OTC) remedies to manage discomfort without the risks of NSAIDs.
New 2025 research reveals key differences between Oropouche fever and dengue virus infections. Learn how to spot predominant symptoms like sore throat and abdominal pain that can help distinguish OROV from DENV during outbreaks in Latin America.
As climate change reshapes ecosystems across Latin America, a silent viral threat is emerging: the Oropouche virus (OROV). Once confined to forested regions, OROV is now infecting thousands in urban centers—spread by tiny midges thriving in warmer, wetter environments. With no vaccine or treatment, and symptoms that mimic dengue, the virus is spreading under the radar. This article explores how deforestation, rising temperatures, and rapid urbanization are fueling OROV’s rise, and what must be done to stop it.
Climate change is fueling dengue outbreaks in Latin America. Learn how extreme heat and AI models in Brazil are reshaping global disease surveillance.
Figure 1. Anti-dengue campaign in Autlán, Mexico. Source: perliux via Flickr. Like Colombia and other Latin American countries, Mexico has faced growing threats from Aedes aegypti– borne viruses such as dengue, chikungunya, and Zika. Statistically speaking, dengue cases surged by 385 % in Mexico during epidemiological week 24 of 2024. Shockingly, 59% of these cases…
